Trial Profile
Effect of ezetimibe/statin combination therapy in patients with type 2 diabetes and dyslipidemia on remnant and inflammation.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 19 Aug 2009 New trial record